Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Twist Bioscience Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Twist Bioscience Corp, Medical Devices Deals, 2012 to YTD 2018 10
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Twist Bioscience Raises Additional USD27 Million in Venture Financing 13
Twist Bioscience Raises USD33 Million in Venture Financing 15
Twist Bioscience Raises USD2.6 Million Financing 16
Twist Bioscience Raises USD61 Million in Series D Venture Financing 17
Twist Bioscience Raises USD37 Million in Series C Venture Financing 19
Twist Bioscience Raises USD26 Million in Series B Financing 21
Twist Bioscience Secures USD9.11 Million in Series A Funding 22
Twist Bioscience Raises US$4.7 Million In Series A Financing 23
Partnerships 24
Twist Bioscience and Desktop Genetics Enter into Partnership 24
Genome Compiler Enters into Integration Agreement with Addgene 25
Genome Compiler Enters into Co-Development Agreement with De Novo DNA 26
Equity Offering 27
Twist Bioscience Prices IPO of Shares for USD70 Million 27
Twist Bioscience Raises USD1 Million in Private Placement of Series D Preferred Shares 28
Twist Bioscience Raises USD11 Million in Private Placement of Series D Preferred Shares 29
Twist Bioscience Raises USD50 Million in Private Placement of Shares 30
Twist Bioscience Corp – Key Competitors 31
Twist Bioscience Corp – Key Employees 32
Twist Bioscience Corp – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 34
Strategy And Business Planning 34
Feb 28, 2018: Twist Bioscience Expands North American Presence With Office in San Diego, California 34
Corporate Communications 35
Oct 24, 2018: Twist Bioscience names Ray Tabibiazar, M.D., as senior vice president, corporate development and business strategy 35
Jun 20, 2018: Twist Bioscience Appoints Jim Thorburn CFO And Aaron Sato As CSO Of Pharma 36
Legal and Regulatory 37
Oct 29, 2018: Agilent sends letter to the SEC regarding Material Misstatements in Twist Bioscience’s S-1 registration statement 37
Sep 18, 2018: Agilent Files New Complaint Against Twist Bioscience Regarding Stolen Agilent Confidential Documents 38
Government and Public Interest 39
Sep 18, 2018: Twist Bioscience Responds to Agilent’s Latest Specious Claims 39
Jul 17, 2017: Sphere Fluidics and Partners Win Major InnovateUK Grant to Develop the World’s First Desktop Genome Editing System 40
Product News 41
Jun 18, 2018: Twist Bioscience Expands Human Core Exome and Custom Next-Generation Sequencing Solutions with High Throughput Offering 41
Feb 14, 2018: Twist Bioscience Launches Exome and Custom Target Enrichment Solutions for Genomics and Clinical Researchers Conducting Next-Generation Sequencing 42
Other Significant Developments 43
Jul 11, 2017: Quintara Biosciences Partners with Twist Bioscience to Launch New Gene Fragment and Cloning Services, qBlocks and qGenes 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Key Facts 2
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Twist Bioscience Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Twist Bioscience Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Twist Bioscience Corp, Medical Devices Deals, 2012 to YTD 2018 10
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Twist Bioscience Raises Additional USD27 Million in Venture Financing 13
Twist Bioscience Raises USD33 Million in Venture Financing 15
Twist Bioscience Raises USD2.6 Million Financing 16
Twist Bioscience Raises USD61 Million in Series D Venture Financing 17
Twist Bioscience Raises USD37 Million in Series C Venture Financing 19
Twist Bioscience Raises USD26 Million in Series B Financing 21
Twist Bioscience Secures USD9.11 Million in Series A Funding 22
Twist Bioscience Raises US$4.7 Million In Series A Financing 23
Twist Bioscience and Desktop Genetics Enter into Partnership 24
Genome Compiler Enters into Integration Agreement with Addgene 25
Genome Compiler Enters into Co-Development Agreement with De Novo DNA 26
Twist Bioscience Prices IPO of Shares for USD70 Million 27
Twist Bioscience Raises USD1 Million in Private Placement of Series D Preferred Shares 28
Twist Bioscience Raises USD11 Million in Private Placement of Series D Preferred Shares 29
Twist Bioscience Raises USD50 Million in Private Placement of Shares 30
Twist Bioscience Corp, Key Competitors 31
Twist Bioscience Corp, Key Employees 32
Twist Bioscience Corp, Other Locations 33
Twist Bioscience Corp, Subsidiaries 33
List of Figures
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Twist Bioscience Corp, Medical Devices Deals, 2012 to YTD 2018 10